Target intelligence / Profile preview

Centrosomal protein 89 (CEP89)

Target
CEP89
Molecular classification
Other (Centrosomal protein), Coiled-coil domain-containing protein, Protein involved in cilium assembly
01

Overview

Centrosomal protein 89 (CEP89) is a coiled-coil domain-containing protein predominantly localized to the centrosome and mitochondria. It is essential for the formation of non-motile cilia (ciliogenesis) and plays a critical role in mitochondrial metabolism by regulating cytochrome c oxidase (Complex IV) activity, which affects cellular energy production and mitochondrial integrity. Pathogenic mutations in CEP89 cause various multisystem disorders, including mitochondrial complex IV deficiency, which can manifest as myopathy, hepatomegaly, cardiomyopathy, developmental delay, and intellectual disability. CEP89 is overexpressed in ovarian cancer, where it acts as an independent prognostic marker for poor overall survival, suggesting a possible oncogenic role and making it a candidate for targeted therapeutic development. No drugs directly targeting CEP89 are currently known.

Other names
Centrosomal protein of 89 kDaCEP89CCDC123Cep89Cep123FLJ14640Centrosomal protein 123Coiled-coil domain-containing protein 123CEP123coiled-coil domain containing 123centrosomal protein 89kDamitochondrial CEP89
02

Biological functions

Ciliogenesis (required for assembly of non-motile cilia)Mitochondrial metabolism (modulation of Complex IV activity, mitochondrial integrity)Synaptic transmission, neuronal functionOrganelle biogenesis and maintenance
03

Disease associations

Mitochondrial complex IV deficiencyMultisystem disorders (e.g., intellectual disability, hepatomegaly, muscle weakness)Prognostic marker in ovarian cancer and potential therapeutic target in ovarian cancer
04

Biomarkers

CEP89 overexpression as a prognostic biomarker for poor overall survival in ovarian cancer

Beyond the preview

Go deeper on Centrosomal protein 89 (CEP89).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrosomal protein 89 (CEP89).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call